Clinical trial
Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity…
NCT00216918 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00216918 |
|---|---|
| Title | Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder. |
| Official title | An Open-Label Pilot Study of Atomoxetine Hydrochloride to Evaluate Neuropsychological Function in Children Ages 6 to 10 Years With Attention-Deficit/Hyperactivity Disorder. |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine Hydrochloride |
| Enrollment | 40 |
| Start date | Sep 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: